Evoxcare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
- Revenue Growth 294.77%
- Profit Growth 136.05%
- Ebitda 498.56%
- Net Worth 318.01%
- Total Assets 29.61%
About Evoxcare Pharmaceuticals
Evoxcare Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2020 (Four years and four months 6 days old ). Its registered office is in Rupnagar, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.00 M.
Kulvinder Singh and Sukhraj Singh serve as directors at the Company.
Company Details
-
Location
Rupnagar, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100PB2020PTC051983
-
Company No.
051983
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Sep 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Evoxcare Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kulvinder Singh
|
Director | 30-Sep-2020 | Current |
|
Sukhraj Singh
|
Director | 30-Sep-2020 | Current |
Financial Performance of Evoxcare Pharmaceuticals.
Evoxcare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 294.77% increase. The company also saw a substantial improvement in profitability, with a 136.05% increase in profit. The company's net worth Soared by an impressive increase of 318.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evoxcare Pharmaceuticals?
Unlock access to Evoxcare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Bioteam Pharmaceutical Private LimitedKulvinder Singh is a mutual person
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2023 | Others | ₹9.00 M | Open |
How Many Employees Work at Evoxcare Pharmaceuticals?
Evoxcare Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evoxcare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evoxcare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.